Is Initial Dasatinib-Blinatumomab Therapy for Ph-Positive ALL in Adults Cost Effective?

被引：0
|
作者：
Bitran, Jacob D. [1 ]
Nabrinsky, Edward [2 ]
Bufalino, Shams [3 ]
Knouse, Phillip [2 ]
Galvez, Angel G. [2 ]
机构：
[1] Advocate Lutheran Gen Hosp, Bone Marrow Transplantat Program, Hematol & Oncol IM, Park Ridge, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[3] Advocate Lutheran Gen Hosp, Bone Marrow Transplantat Program, Park Ridge, IL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-144656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4962
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia A case report
    Wang, Jing
    Shen, Shu-Hong
    Hu, Bin-Fei
    Wang, Guan-Ling
    MEDICINE, 2021, 100 (25) : E26440
  • [42] FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission
    Deane, M
    Koh, M
    Foroni, L
    Galactowicz, G
    Hoffbrand, AV
    Lawler, M
    Secker-Walker, L
    Prentice, HG
    BONE MARROW TRANSPLANTATION, 1998, 22 (12) : 1137 - 1143
  • [43] FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission
    M Deane
    M Koh
    L Foroni
    G Galactowicz
    AV Hoffbrand
    M Lawler
    L Secker-Walker
    HG Prentice
    Bone Marrow Transplantation, 1998, 22 : 1137 - 1143
  • [44] Successful autologous stem cell transplantation in Ph-positive ALL patient with refractory invasive pulmonary aspergillosis
    I Lisukov
    S Sizikova
    A Kulagin
    I Kruchkova
    A Gilevich
    I Klimova
    V Kozlov
    Bone Marrow Transplantation, 2004, 34 : 559 - 560
  • [45] Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph-positive chronic myelocytic leukemia
    Zhang, XW
    Ji, LX
    Liu, SH
    Wang, JX
    LEUKEMIA RESEARCH, 2003, 27 (04) : 367 - 369
  • [46] Identification of a new mechanism of resistance to imatinib and dasatinib in PH-positive acute lymphoblastic leukemia: Overexpression of aberrantly spliced oncogenic Ikaros informs
    Iacobucci, I.
    Soverini, S.
    Paolini, S.
    Piccaluga, P. P.
    Rondori, M.
    Ottaviani, E.
    Amabile, M.
    Poerio, A.
    Castagnetti, F.
    Giannoulia, P.
    Colarossi, S.
    Gnari, A.
    Cillori, D.
    Saglio, G.
    Pane, F.
    Rosti, G.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 2 - 3
  • [47] DEBATE: IN PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA, DE WE NEED CHEMOTHERAPY IN INDUCTION THERAPY?
    Ribera, Josep-Maria
    LEUKEMIA RESEARCH, 2015, 39 : SS3 - SS3
  • [48] Potential therapy for Ph1-ALL and CML tumors unresponsive to imatinib and/or dasatinib
    Nature Clinical Practice Oncology, 2008, 5 (1): : 6 - 6
  • [49] Phase II Study of Combination of hyperCVAD with Dasatinib in Frontline Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Ravandi, Farhad
    Thomas, Deborah
    Kantarjian, Hagop
    Faderl, Stefan
    Koller, Charles
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Borthakur, Gautam
    Wierda, William
    Burger, Jan
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2008, 112 (11) : 1005 - 1005
  • [50] The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
    Morishita, Takanobu
    Hayakawa, Fumihiko
    Sugimoto, Keiki
    Iwase, Mizuho
    Yamamoto, Hideyuki
    Hirano, Daiki
    Kojima, Yuki
    Imoto, Naoto
    Naoe, Tomoki
    Kiyoi, Hitoshi
    ONCOTARGET, 2016, 7 (35) : 56241 - 56252
12345